Changes in diastolic time with various pharmacologic agents: implication for myocardial perfusion

Circulation. 1979 Jul;60(1):164-9. doi: 10.1161/01.cir.60.1.164.

Abstract

Diastolic time (DT) is calculated as the cycle length (RR) minus electromechanical systole (QS2). The ratio of DT (RR-QS2) to RR interval times 100, or the percent diastole (%D), varies nonlinearly with heart rate (HR), increasing rapidly with decreasing HR. The effect of commonly used cardioactive agents on %D was studied in five groups of normal subjects. In group 1 (n = 12), propranolol (160 mg daily) increased %D from 55.9 +/- 1.7 to 64.7 +/- 1.3 (p less than 0.001) by slowing HR. In group 2 (n = 12), dobutamine (2.5 micrograms/kg/min) increased %D from 56.4 +/- 1.4 to 61.8 +/- 1.3 (p less than 0.005) by shortening the QS2. In group 3 (n = 10), Cedilanid-D (1.6 mg i.v.) increased %D from 55.5 +/- 1 to 63.2 +/- 0.7 (p less than 0.001), both by slowing the HR and shortening the QS2. In group 4 (n = 12), isoproterenol (2 micrograms/min) increased HR and shortened the QS2 significantly. The net result was a significant reduction of %D from 56.1 +/- 1.4 to 53.5 +/- 1.1, (p less than 0.05). In group 5 (n = 15), a 100-mg bolus of i.v. lidocaine did not have a significant effect on %D. This study indicates that cardiovascular drugs may have significant effects on the relative duration of diastole either by affecting HR or the duration of systole. This may have clinical implications for patients with coronary artery disease and patients with left ventricular hypertrophy, since in both cases coronary flow in mostly diastolic.

Publication types

  • Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Oral
  • Adolescent
  • Adult
  • Cardiovascular Agents / pharmacology*
  • Clinical Trials as Topic
  • Coronary Circulation*
  • Deslanoside / administration & dosage
  • Deslanoside / pharmacology
  • Diastole / drug effects*
  • Dobutamine / administration & dosage
  • Dobutamine / pharmacology
  • Heart Rate / drug effects
  • Humans
  • Infusions, Parenteral
  • Injections, Intravenous
  • Isoproterenol / administration & dosage
  • Isoproterenol / pharmacology
  • Lidocaine / administration & dosage
  • Lidocaine / pharmacology
  • Male
  • Myocardial Contraction / drug effects*
  • Propranolol / administration & dosage
  • Propranolol / pharmacology
  • Time Factors

Substances

  • Cardiovascular Agents
  • Dobutamine
  • Lidocaine
  • Propranolol
  • Isoproterenol
  • Deslanoside